Physician profile
Brook C Hunter
NPI 1952717274
$373.91
in general payments reported to CMS, 2019-2025
8 companies · $59.47 in 2025
The $59.47 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $152 · 2023: $72.06 · 2024: $90.08 · 2025: $59.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $85.00 | 2022 | |
| Merck Sharp & Dohme LLC | $80.13 | 2023-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.81 | 2023-2025 | Jardiance |
| Chiesi USA, INC. | $40.43 | 2022-2024 | Cleviprex, Kengreal |
| Cumberland Pharmaceuticals, INC. | $34.49 | 2022 | |
| Vifor Pharma, INC. | $20.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.62 | 2023 | |
| Janssen Pharmaceuticals, INC | $17.86 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brook Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.